Source: Eur Respir J 2006; 27: 779-787



Rating:

Share or cite this content

Citations should be made in the following way:
Vanaudenaerde B. M., Dupont L. J., Wuyts W. A., Verbeken E. K., Meyts I., Bullens D. M., Dilissen E., Luyts L., Van Raemdonck D. E., Verleden G. M.. The role of interleukin-17 during acute rejection after lung transplantation. Eur Respir J 2006; 27: 779-787

Member's Comments

No comment yet.

Related content which might interest you: Pleural fluid cytokines after lung transplantation as markers of acute rejection development Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Increased soluble CD14 in bronchoalveolar lavage fluid of stable lung transplant recipients Source: Eur Respir J 2002; 19: 472-478 Year: 2002 Non-compartmentalisation of inflammatory cytokines in bronchoalveolar lavage T cells of stable lung transplant patients Source: Eur Respir J 2005; 26: Suppl. 49, 176s Year: 2005 Bronchoalveolar lavage neuregulin-1 is elevated in acute lung injury and correlates with inflammation Source: Eur Respir J 2013; 41: 396-401 Year: 2013 Frequency of interferon-gamma (IFN-γ) producing lymphocytes in BAL of lung transplanted patients with acute rejection (AR) Source: Eur Respir J 2001; 18: Suppl. 33, 297s Year: 2001 Evaluation of bronchoalveolar cells in pulmonary paracoccidioidomycosis Source: Eur Respir J 2003 Dec 01;22(6):895-899 Year: 2003 Pronounced neutrophil-rich inflammation in induced sputum of lung transplant recipients with chronic rejection Source: Eur Respir J 2001; 18: Suppl. 33, 297s Year: 2001 Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease Source: Eur Respir J 2011; 37: 1378-1385 Year: 2011 M2 polarized macrophages in bronchoalveolar lavage of lung transplant recipients Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes Year: 2019 Monocyte chemoattractant protein-1 levels in broncho-alveolar lavage fluid of lung transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection Source: Eur Respir J 2003; 22: Suppl. 45, 326s Year: 2003 Thalidomide reduces IL-18, IL-8 and TNF-α release from alveolar macrophages in interstitial lung disease Source: Eur Respir J 2006 Oct 01;28(4):824-831 Year: 2006 Comparison of differential cell counts and interleukin-8 levels in bronchoalveolar lavage and induced sputum from lung transplant recipients Source: Eur Respir J 2003; 22: Suppl. 45, 201s Year: 2003 Exploring the BAL profile in acute rejection and lymphocytic bronchiolitis after lung transplantation Source: Annual Congress 2009 - Bronchiolitis obliterans syndrome after lung transplantation: pathophysiology and treatment options Year: 2009 Perforin expression and lymphocytes adhesion molecules in patients with pulmonary sarcoidosis Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005 β-Adrenoceptor stimulation and neutrophil accumulation in mouse airways Source: Eur Respir J 2004; 24: 231-237 Year: 2004 Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation Year: 2008 IL8 and IL17 are upregulated in BAL fluid of lung transplant patients with bronchiolitis obliterans syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 465s Year: 2004 Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 HGF and IL-6 in BAL fluid of interstitial lung diseases: effect on human lung fibroblasts Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 Bronchoalveolar lavage fluid leukotrienes in the pathomechanism of acute inflammatory events in lung transplant recipients Source: International Congress 2016 – Monitoring comorbidities Year: 2016